| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |